SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-013993
Filing Date
2024-04-01
Accepted
2024-04-01 15:18:24
Documents
1
Period of Report
2023-10-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1711999092.html 4  
1 FORM 4 wk-form4_1711999092.xml 4 8383
  Complete submission text file 0001628280-24-013993.txt   10189
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CHAMPIONS ONCOLOGY, INC. ONE UNIVERSITY PLAZA STE 307 HACKENSACK NJ 07601
Business Address
Davis Brady (Reporting) CIK: 0002002615 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11504 | Film No.: 24808604